Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 223 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
ORIGINAL ARTICLE Table of Contents   
Year : 2016  |  Volume : 27  |  Issue : 7  |  Page : 51-61
Gulf Cooperation Council-dialysis outcomes and practice patterns study: An overview of anemia management trends at the regional and country specific levels in the Gulf Cooperation Council countries


1 Department of Medicine, Tawam Hospital, Al Ain, United Arab Emirates
2 Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
3 Department of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
4 Department of Medicine, King Saud University, Riyadh, Saudi Arabia
5 Department of Medicine, The Royal Hospital, Muscat, Oman
6 Department of Medicine, Salmaniya Medical Complex, Manama, Bahrain
7 Department of Medicine, Dar Al Shifa Hospital, Hawally, Kuwait
8 Department of Medicine, Hamad General Hospital, Doha, Qatar
9 Arbor Research Collaborative for Health, Ann Arbor, MI, USA
10 List of Study Group in Acknowledgment

Correspondence Address:
Samra Abouchacra
Department of Medicine, Tawam Hospital, Al Ain
United Arab Emirates
Login to access the Email id


DOI: 10.4103/1319-2442.194895

PMID: 27991479

Rights and Permissions

The Gulf Cooperation Council-Dialysis Outcomes and Practice Patterns Study (GCC-DOPPS) marks the joining of the six Gulf region countries including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates to the main DOPPS study in 2012. The current review is a descriptive reporting on results related to the management of anemia from these countries. Our data demonstrate consistent anemia management patterns across the GCC countries allowing the achievement of international treatment levels. Overall, the majority of hemodialysis patients were prescribed appropriate erythropoiesis-stimulating agents (ESAs) and supplemental iron, enabling the attainment of mean hemoglobin (Hb) level of 10.9 g/dL. Comparisons of the individual country profiles reveal individual differences in the choice and mode of ESA and iron administration. However, all countries displayed good compliance with guideline recommendations. The same challenges as elsewhere are faced in the GCC, with respect to optimizing Hb levels and judiciously using ESA and iron supplements. Some opportunities exist for focused efforts to fine tune inter-facility variability in anemia management based on continued data tracking. The latter is vital in enabling adopting new trends to further improve not only anemia management but also the wholesome care of dialysis patients.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed332    
    Printed0    
    Emailed0    
    PDF Downloaded62    
    Comments [Add]    

Recommend this journal